A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors
NCT 06063681 Brief Summary This is an open-label, dose-escalation, multi-center phase 1…
Read more arrow_forwardNCT 06063681 Brief Summary This is an open-label, dose-escalation, multi-center phase 1…
Read more arrow_forwardNCT 05503797 Brief Summary The objective of this Master Protocol is to…
Read more arrow_forwardNCT 05205109 Brief Summary This is a study of ATG-037 Monotherapy and…
Read more arrow_forwardNCT 04913285 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 06326411 Brief Summary This is a two-part Phase 1, open label,…
Read more arrow_forwardNCT 06710847 Brief Summary Solid tumours are abnormal lumps of tissue that…
Read more arrow_forwardNCT 06533059 Brief Summary The purpose of this study is to characterize…
Read more arrow_forwardNCT 06760819 Brief Summary Researchers are looking for a better way to…
Read more arrow_forwardNCT 06597721 Brief Summary Adcendo ApS is conducting a phase 1 study…
Read more arrow_forwardNCT 05906862 Brief Summary This first-in-human study will evaluate the Maximum Tolerated…
Read more arrow_forward